Andrew D. Kosar

Array ( [id] => 23878 [patent_doc_number] => 07795222 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Methods for treating a corneal disorder and promoting skin wound healing' [patent_app_type] => utility [patent_app_number] => 11/725761 [patent_app_country] => US [patent_app_date] => 2007-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6170 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795222.pdf [firstpage_image] =>[orig_patent_app_number] => 11725761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7591212 [patent_doc_number] => 07662857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Diagnostic agents for pancreatic exocrine function' [patent_app_type] => utility [patent_app_number] => 11/716273 [patent_app_country] => US [patent_app_date] => 2007-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13709 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662857.pdf [firstpage_image] =>[orig_patent_app_number] => 11716273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4583765 [patent_doc_number] => 07851448 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Methods for modulating activities in plants' [patent_app_type] => utility [patent_app_number] => 11/681617 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25791 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851448.pdf [firstpage_image] =>[orig_patent_app_number] => 11681617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101767 [patent_doc_number] => 20070185029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Methods of TX Condition In Animal' [patent_app_type] => utility [patent_app_number] => 11/681649 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25780 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185029.pdf [firstpage_image] =>[orig_patent_app_number] => 11681649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6593479 [patent_doc_number] => 20100048460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'SELECTIVE VPAC2 RECEPTOR PEPTIDE AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/278035 [patent_app_country] => US [patent_app_date] => 2007-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11601 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048460.pdf [firstpage_image] =>[orig_patent_app_number] => 12278035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177917 [patent_doc_number] => 07655625 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Methods of treating blepharospasm using cyclosporine components' [patent_app_type] => utility [patent_app_number] => 11/673867 [patent_app_country] => US [patent_app_date] => 2007-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5002 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655625.pdf [firstpage_image] =>[orig_patent_app_number] => 11673867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120575 [patent_doc_number] => 20070142290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'SURFACE-MODIFIED SERUM ALBUMIN-METAL PORPHYRIN COMPOSITE, AND OXYGEN INFUSION SOLUTION CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/673214 [patent_app_country] => US [patent_app_date] => 2007-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6631 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142290.pdf [firstpage_image] =>[orig_patent_app_number] => 11673214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4500673 [patent_doc_number] => 07919466 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Lymphatic zip codes in tumors and pre-malignant lesions' [patent_app_type] => utility [patent_app_number] => 11/670318 [patent_app_country] => US [patent_app_date] => 2007-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 31637 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919466.pdf [firstpage_image] =>[orig_patent_app_number] => 11670318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13793 [patent_doc_number] => 07803766 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Gastrin compositions and formulations, and methods of use and preparation' [patent_app_type] => utility [patent_app_number] => 11/701196 [patent_app_country] => US [patent_app_date] => 2007-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 16068 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803766.pdf [firstpage_image] =>[orig_patent_app_number] => 11701196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927861 [patent_doc_number] => 20080167224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'VARIANTS OF THE NK1 FRAGMENT OF HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR (HGF/SF) AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 11/627761 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7519 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167224.pdf [firstpage_image] =>[orig_patent_app_number] => 11627761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4977903 [patent_doc_number] => 20070219136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Methods and compositions for treating inflammatory disorders' [patent_app_type] => utility [patent_app_number] => 11/655458 [patent_app_country] => US [patent_app_date] => 2007-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7387 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219136.pdf [firstpage_image] =>[orig_patent_app_number] => 11655458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126398 [patent_doc_number] => 20070238669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS' [patent_app_type] => utility [patent_app_number] => 11/622142 [patent_app_country] => US [patent_app_date] => 2007-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 40063 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238669.pdf [firstpage_image] =>[orig_patent_app_number] => 11622142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 439728 [patent_doc_number] => 07259237 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-08-21 [patent_title] => 'Pan-antiviral peptides' [patent_app_type] => utility [patent_app_number] => 11/648773 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7020 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/259/07259237.pdf [firstpage_image] =>[orig_patent_app_number] => 11648773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6353762 [patent_doc_number] => 20100331520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'METASTIN DERIVATIVES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/158251 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52180 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331520.pdf [firstpage_image] =>[orig_patent_app_number] => 12158251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5041145 [patent_doc_number] => 20070093427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Membrane-permeable NFAT inhibitory peptide' [patent_app_type] => utility [patent_app_number] => 11/633529 [patent_app_country] => US [patent_app_date] => 2006-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6294 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093427.pdf [firstpage_image] =>[orig_patent_app_number] => 11633529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4569968 [patent_doc_number] => 07858585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Hydrogels and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/598763 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 63 [patent_no_of_words] => 34591 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858585.pdf [firstpage_image] =>[orig_patent_app_number] => 11598763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4579331 [patent_doc_number] => 07833986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Anti-inflammatory peptides' [patent_app_type] => utility [patent_app_number] => 11/594319 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8174 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/833/07833986.pdf [firstpage_image] =>[orig_patent_app_number] => 11594319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 303625 [patent_doc_number] => 07534763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-19 [patent_title] => 'Sustained release GLP-1 receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/594531 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 41691 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/534/07534763.pdf [firstpage_image] =>[orig_patent_app_number] => 11594531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183512 [patent_doc_number] => 20070054866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation' [patent_app_type] => utility [patent_app_number] => 11/593699 [patent_app_country] => US [patent_app_date] => 2006-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6967 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054866.pdf [firstpage_image] =>[orig_patent_app_number] => 11593699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688938 [patent_doc_number] => 20070105760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Process for the preparation of echinocandin derivatives' [patent_app_type] => utility [patent_app_number] => 11/591898 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7243 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105760.pdf [firstpage_image] =>[orig_patent_app_number] => 11591898 [rel_patent_id] =>[rel_patent_doc_number] =>)